Roddy and Ganz Assessments

profileOgh
journal_of_evaluation_in_clinical_practice.docx

Journal of Evaluation in Clinical Practice,

12

, 3, 347–352

©

2006 Blackwell Publishing Ltd

347

Blackwell Science, LtdOxford, UKJEPJournal of Evaluation in Clinical Practice1356-1294Blackwell Publishing Ltd 200512

3347352

Original ArticleGrading strength of guideline recommendationsE. Roddy

et al.

Correspondence

Edward Roddy

Academic Rheumatology

Clinical Sciences Building

Nottingham City Hospital

Hucknall Road

NG5 1PB

UK

E-mail:

[email protected]

Keywords:

clinical guidelines,

evidence-based medicine, strength of

recommendation

Accepted for publication:

27 April 2005

Evidence-based clinical guidelines: a new system to better determine

true strength of recommendation

Edward Roddy MRCP (Specialist Registrar in Rheumatology),

1

Weiya Zhang PhD (Senior Lecturer in

Musculoskeletal Epidemiology),

1

Michael Doherty MA MD FRCP (Professor of Rheumatology),

1

Nigel K. Arden MD MSc MRCP (Senior Lecturer in Rheumatology),

2

Julie Barlow PhD (Professor of Health

Psychology),

3

Fraser Birrell MA PhD MRCP (Senior Lecturer in Rheumatology),

4

Alison Carr PhD (Special Lecturer

in Musculoskeletal Epidemiology),

1

Kuntal Chakravarty FRCP (Consultant Rheumatologist),

5

John Dickson FRCP MRCGP (Community Specialist in Rheumatology),

6

Elaine Hay MD FRCP (Professor of

Community Rheumatology),

7

Gillian Hosie FRCP (General Practitioner),

8

Michael Hurley PhD (Reader in

Physiotherapy & ARC Research Fellow),

9

Kelsey M. Jordan MRCP (Rheumatology Research Fellow),

2

Christopher McCarthy PhD (Research Physiotherapist),

10

Marion McMurdo MD FRCP (Professor of Ageing and

Health),

11

Simon Mockett MPhil (Senior Lecturer),

12

Sheila O’Reilly MD MRCP (Consultant Rheumatologist),

13

George Peat PhD MCSP (Research Fellow),

7

Adrian Pendleton MD MRCP (Specialist Registrar in Rheumatology),

14

Selwyn Richards MA MSc FRCP (Consultant Rheumatologist)

15

1

Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Hucknall Road, Nottingham, UK

2

MRC Epidemiology Resource Centre, Southampton General Hospital, Tremona Road, Southampton, Hampshire, UK

3

Interdisciplinary Research Centre in Health, School of Health and Social Sciences, Coventry University, Priory St,

Coventry, UK

4

Musculoskeletal Research Group, University of Newcastle upon Tyne, UK

5

Haroldwood Hospital, Gubbins Lane, Romford, Essex, UK

6

Langbaurgh PCT, Langbaurgh House, Bow Street, Guisborough, Cleveland, UK

7

Primary Care Sciences Research Centre, Keele University, Staffordshire, UK

8

Primary Care Rheumatology Society, Northallerton, North Yorkshire, UK

9

King’s College London, Rehabilitation Research Unit, Dulwich Hospital, East Dulwich Grove, London, UK

10

The Centre for Rehabilitation Science, University of Manchester, Oxford Road, Manchester, UK

11

Department of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK

12

Division of Physiotherapy Education, School of Community Health Sciences, University of Nottingham, Nottingham City

Hospital, Hucknall Road, Nottingham, UK

13

Derbyshire Royal Infirmary, London Road, Derby, UK

14

Craigavon Area Hospital, 68 Lurgan Road, Portadown, Co Armagh, UK

15

Poole Hospital, Longfleet Road, Poole, UK

Abstract

Rationale, aims and objectives

Clinical practice guidelines often grade the

‘strength’ of their recommendations according to the robustness of the supporting

research evidence. The existing methodology does not allow the

strength of recommendation (SOR) to be upgraded for recommendations

for which randomized controlled trials are impractical or unethical. The purpose

of this study was to develop a new method of determining SOR, incorporating

both research evidence and expert opinion.

Methods

A Delphi

technique was employed to produce 10 recommendations for the role of

exercise therapy in the management of osteoarthritis of the hip or knee. The

SOR for each recommendation was determined by the traditional method,

closely linked to the category of research evidence found on a systematic

literature search, and on a visual analogue scale (VAS). Recommendations

were grouped A-D according to the traditional SOR allocated and the

mean VAS calculated. Difference across the groups was assessed by oneE.

Roddy

et al.

348

©

2006 Blackwell Publishing Ltd,

Journal of Evaluation in Clinical Practice

,

12

, 3, 347–352

way

ANOVA

variance analysis.

Results

Mean VAS scores for the traditional

SOR groups A-D and one proposition which was ‘not recommended’

showed significant linearity on one-way

ANOVA

. However, certain recommendations

which, for practical reasons, could not assessed in randomized

controlled trials and therefore could not be recommended strongly by the

traditional methodology, were allocated a strong recommendation by VAS.

Conclusions

This new system of grading strength of SOR is less constrained

than the traditional methodology and offers the advantage of

allowing SOR for procedures which cannot be assessed in RCTs for practical

or ethical reasons to be upgraded according to expert opinion.

Introduction

Clinical guidelines have been defined as ‘systematically

developed statements to assist practitioner

and patient decisions about appropriate health care

for specific clinical conditions’ (Field & Lohr 1990).

Guidelines that employ an evidence-based format

currently grade each recommendation in two ways:

first, by classifying the ‘category of evidence’ and,

second, by giving a ‘strength of recommendation’.

Although several methods of producing such grades

are described, in most of these, including the method

most commonly used by clinical guidelines in rheumatology

(Pendleton

et al

. 2000; Jordan

et al

. 2003;

Dougados

et al

. 2004; Zhang

et al

. 2004; Roddy

et al

.

2005), the latter is strongly dependent on the former

(Shekelle

et al

. 1999) (Table 1). That is, the strength

of recommendation (SOR) primarily reflects the

robustness of the research evidence, with evidence

from randomized controlled trials (RCTs) and

systematic reviews automatically conferring the

strongest recommendation. However, although this

traditional method allows a downgrading of the SOR

for reasons including side effects or inconsistent

studies, it does not allow an upgrading of recommendations

in situations where RCTs are impractical or

unethical, e.g. total joint replacement, but effectiveness

is not in doubt. Furthermore, the practice of

evidence-based medicine requires the integration of

clinical expertise with the best available evidence

from systematic research (Sackett

et al

. 1996). During

the development of recent recommendations for

the role of exercise in the management of osteoarthritis

(OA) of the hip or knee (Roddy

et al

. 2005),

we found that the SOR allocated by this method was

often discordant with the consensus opinion of the

Table 1 Traditional hierarchy for category of evidence and strength of recommendation (Shekelle

et al

. 1999)

Categories of evidence

1A. meta-analysis of RCT

1B. at least one RCT

2A. at least one CT without randomization

2B. at least one type of quasi-experimental study

3. descriptive studies (comparative, correlation, case-control)

4. expert committee reports/opinions and/or clinical opinion of respected authorities

Strength of recommendation

A. Directly based on category 1 evidence

B. Directly based on category 2 evidence or extrapolated recommendation from category 1 evidence

C. Directly based on category 3 evidence or extrapolated recommendation from category 1 or 2 evidence

D. Directly based on category 4 evidence or extrapolated recommendation from category 1, 2 or 3 evidence

RCT, randomized controlled trial; CT, controlled trial.

Grading strength of guideline recommendations

©

2006 Blackwell Publishing Ltd,

Journal of Evaluation in Clinical Practice

,

12

, 3, 347–352

349

panel. Therefore, we developed an alternative

method to better capture the true opinion of the

panel, whilst still requiring them to consider the

research evidence. We examined whether this alternative

approach affected the support afforded to

each recommendation.

Methods

A multi-disciplinary panel employed a Delphi technique

to produce 10 recommendations relating to

the role of exercise in the management of OA of

the hip or knee (Roddy

et al

. 2005). Following a

literature search and summary analysis of results,

the evidence for each recommendation was

assessed. The category of evidence and SOR was

assigned for each according to the method previously

described (Shekelle

et al

. 1999). In addition,

each participant was asked to indicate how strongly

they rated each recommendation, based not just on

research evidence but also on all aspects relating

to their knowledge and clinical opinion. This was

recorded using a 10-cm visual analogue scale (VAS)

anchored with two descriptors labelled ‘not recommended

at all’ at the far left (0 cm) and ‘fully recommended’

at the far right (10 cm). The mean VAS

and standard deviation for each recommendation

were calculated. The recommendations were then

grouped according to their original SOR (A-D) and

the mean VAS and 95% confidence interval calculated

for each group. A one-way

ANOVA

variance

analysis was performed to assess the difference

between the groups.

Results

The recommendations and the categories of evidence,

SOR and VAS for each, are shown in Table 2.

Figure 1 shows the mean VAS and 95% confidence

interval for recommendation groups A, C and D in

addition to one recommendation which was contradicted

by the research evidence and could not therefore

be graded according to the traditional method

(‘not recommended’). No recommendations were

allocated a grade B SOR. The one-way

ANOVA

variance

analysis identified a significant difference across

the groups (

P

<

0.001) and significant linearity

(

P

<

0.001).

Discussion

There was similarity between the SOR produced by

this method and the traditional methodology (Shekelle

et al

. 1999). The mean VAS for each recommendation

group (A, C, D) increased with the traditional

SOR, and therefore the category of evidence, and the

lowest mean was seen for the recommendation which

could not be recommended by the research evidence

ie was based solely on expert opinion.

This new system has the advantage of allowing the

SOR to be upgraded or downgraded based on expert

opinion relating to global aspects of health

care delivery, such as generalizability, safety, costeffectiveness

and patient preference, and common

sense. It therefore gives an additional dimension and

weighting to guideline recommendations other than

just the support from research evidence alone. In the

traditional system, the term ‘strength of recommendation’

is almost a misnomer as it directly relates

to the category of evidence and provides little extra

information beyond that afforded by the ‘category of

evidence’. This is an important limitation of currently

practised evidence-based guideline methodology

that was overlooked in a recent critique of the methodology

of OA guidelines (Pencharz

et al

. 2002).

During the development of guidelines there are

many situations for which the existing SOR methodology

(Shekelle

et al

. 1999) is not ideal. Interventions

for which placebo-controlled trials are impractical or

unethical (e.g. total joint replacement) cannot score

highly on the existing hierarchy and yet clearly may

Figure 1 Comparison of mean VAS (95% confidence

intervals) and traditional strength of recommendation.

VAS, visual analogue scale; NR, not recommended.

0

1

2

3

4

5

6

7

8

9

A C D NR

Strength of recommendation (Traditional method)

Mean VAS (cm)

VAS = visual analogue scale, NR = not recommended

E. Roddy

et al.

350

©

2006 Blackwell Publishing Ltd,

Journal of Evaluation in Clinical Practice

,

12

, 3, 347–352

be very efficacious and warrant strong recommendation

for clinical practice. The new method allows

the recommendation for such interventions to be

upgraded beyond that afforded by the category of

research evidence. Furthermore, when recommendations

are not easily assessed in the setting of a clinical

trial yet have clear face validity, as with our third and

fourth recommendations (Table 2), the panel may

feel a much stronger recommendation is warranted

than that permitted by the current research-linked

method. For example, the mean VAS for both propositions

4 and 5B (Table 2) was 7.7, yet the SOR

according to the traditional methodology were D and

1B respectively. This reflects that although proposition

4 would be impractical to assess in the setting of

a RCT, it was highly supported by the expert panel

Table 2 Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or

knee: category of evidence, strength of recommendation (Shekelle

et al

. 1999) and visual analogue score (VAS)

Recommendation

Category of

Evidence (1–4)

Strength of

Recommendation (A-D)

Strength of

recommendation

(VAS) – Mean

(SD) cms

1. Both strengthening and aerobic exercise can

reduce pain and improve function and health

status in patients with knee and hip OA.

Knee 1B

Hip 4

A

C (extrapolated from knee OA)

8.9 (1.1)

6.3 (2.1)

2. There are few contra-indications to the

prescription of strengthening or aerobic

exercise to patients with hip or knee OA.

4 C (extrapolated from adverse

event data)

8.0 (1.5)

3. Prescription of both general (aerobic

fitness training) and local (strengthening)

exercises is an essential, core aspect of

management for every patient with hip or

knee OA.

4 D 7.1 (2.5)

4. Exercise therapy for OA of the hip or knee

should be individualized and patient-centred

taking into account factors such as age,

co-morbidity and overall mobility.

4 D 7.7 (1.9)

5. To be effective, exercise programmes

should include advice

and education to promote a positive lifestyle

change with an increase in physical activity.

4

1B

D

A

6.1 (2.6)

7.7 (1.4)

6. Group exercise and home exercise are equally

effective and patient preference should be

considered.

1A

4

A

D

8.0 (1.5)

7.6 (2.3)

7. Adherence is the principal predictor of

long-term outcome from exercise in patients

with knee or hip OA.

4 D 5.1 (2.4)

8. Strategies to improve and maintain

adherence should be adopted, e.g. long-term

monitoring/review and inclusion of

spouse/family in exercise.

1B A 7.6 (1.5)

9. The effectiveness of exercise is independent

of the presence or severity of radiographic

findings.

4 Not recommended 4.5 (2.8)

10. Improvements in muscle strength and

proprioception gained from exercise

programmes may reduce the progression of

knee and hip OA.

4 D 4.2 (2.5)

Grading strength of guideline recommendations

©

2006 Blackwell Publishing Ltd,

Journal of Evaluation in Clinical Practice

,

12

, 3, 347–352

351

whereas robust evidence from RCTs exists to support

proposition 5B. Finally, the traditional hierarchy

does not accommodate the scenario where research

evidence contradicts a recommendation, as with our

ninth recommendation (Table 2).

Other guideline methodology groups have

attempted to overcome these limitations and reduce

the dependence of the SOR on the category of

research evidence. However, the grading systems,

produced by American College of Cardiology/

American Heart Association (ACC/AHA) Task

Force (ACA/AHA 2004), the US Preventive Services

Task Force (2003), the National Institute for Clinical

Excellence (NICE) (NICE 2004) and the New

Zealand Guidelines Group (New Zealand Guidelines

Group 2004), derive the SOR primarily from

the category of research evidence. The ACC/AHA

guidelines state that any combination of classification

of recommendation and level of evidence is possible

and that a recommendation can be strongly supported

even if it is based entirely on expert opinion

and no research studies have ever been conducted on

the recommendation (ACA/AHA 2004). However,

this system does not provide for the incorporation of

factors such as cost-effectiveness and safety, and the

descriptive and quantitative criteria for assigning the

classification and evidence ratings weight research

evidence and clinical expertise equally, which may

not be appropriate for some modalities, e.g. total

joint replacement. The guideline development

methods of NICE state that when the evidence is

very strong, this should translate directly into a recommendation,

yet when the literature search finds no

evidence to answer the clinical question, the guideline

development group should consider using consensus

methods to identify current best practice,

suggesting that consensus methods are only needed

when there is no robust evidence (NICE 2004).

Furthermore, NICE produces guidance on the role of

individual treatments rather than disease-orientated

recommendations on global treatment strategies. The

recently published GRADE collaboration (Atkins

et al

. 2004), although highlighting the difficulties in

producing clinical guidelines and grading strength of

recommendation, has not produced a simple, practical

solution. The VAS, on the other hand, has the

advantage of being simple to apply and allows all

facets to be incorporated, e.g. category of research

evidence, safety, cost-effectiveness, generalizability

and expert opinion.

A limitation of the VAS-SOR methodology is that

as the basis for the VAS is not based on explicit

criteria, it cannot be examined and assessed readily

by external groups. However, we recommend that

the VAS method should be used alongside the traditional

method of determining the category of

research evidence supporting each recommendation.

Any discrepancy between the category of evidence

and SOR would therefore be highlighted and should

then be justified in the ensuing discussion. A further

limitation is that this method has only been used

in the setting of recommendations for exercise in

osteoarthritis by a single group of experts, so evidence

of its generalizability to other fields and other

groups is required.

Other possible methods for grading SOR include

the development of an ordinal scale. A numerical

scale, however, is commonly used to assess selfreported

pain and disability in clinical trials, and

applying this principle to SOR seemed preferable.

Although the numerical scale scores themselves do

not have intrinsic comparability between different

sets of guidelines, there is at least scope for grading

or even ranking of different recommendations within

each set of guidelines. Other groups that prefer

verbal scales may wish to develop an ordinal scale

with descriptors to help guide practice in a clinical

setting.

Our guideline development group concludes that,

in comparison to existing traditional methodology,

this new system of grading SOR is less constrained

and offers the advantage of allowing the SOR for

procedures which cannot be assessed in RCTs to be

upgraded according to expert opinion consistent with

the principles of evidence-based medicine (Sackett

et al

. 1996). We would encourage other groups that

develop management recommendations or guidelines

to try this approach, so that its clinical applicability

and usefulness can be determined more widely.

Acknowledgements

We are grateful for an educational grant from

MOVE (http://www.move.uk.net) and are also

indebted to the Arthritis Research Campaign, UK

for financial support (ICAC grant D0593; WZ Senior

E. Roddy

et al.

352

©

2006 Blackwell Publishing Ltd,

Journal of Evaluation in Clinical Practice

,

12

, 3, 347–352

Lectureship D0565). We would also like to thank Dr

Jinying Lin, a visiting scholar from The People’s

Hospital of Guangxi Province, China, for assistance

with data entry.

John Dickson during the past 5 years has received

support to attend or organize symposia, or has

received a speaker’s honoraria, or a board member’s

honoraria from one or more of the following companies

– MSD, Wyeth, Pfizer, BI, TSB Chemedica,

GSK. He has received research funding from Q-med.

He has shares in Merck and Pfizer.

Marion McMurdo is a Director of D D Developments

Limited, a University of Dundee company

whose mission is to provide exercise opportunities

for older people. Profits go to ageing research.

References

American College of Cardiology/American Heart Association

(2004)

Manual for ACC/AHA Guideline Writing

Committees. Section II: Tools and Methods for Creating

Guidelines. Step Six: Assign Classification of Recommendations

and Level of Evidence.

Available at:

http://www.acc.org/clinical/manual/manual_Iistep6.htm

(accessed 13 July 2004).

Atkins D., Best D., Briss P.A.

et al.

(2004) Grading quality

of evidence and strength of recommendations.

BMJ

328

,

1490.

Dougados M., Betteridge N., Burmester G.R.

et al.

(2004)

EULAR standardised operating procedures for the

elaboration, evaluation, dissemination, and implementation

of recommendations endorsed by the EULAR

standing committees.

Annals of the Rheumatic Disease

63

, 1172–1176.

Field M. & Lohr K. (1990)

Clinical Practice Guidelines:

Directions for a New Program

. National Academy Press,

Washington DC.

Jordan K.M., Arden N.K., Doherty M.

et al.

(2003)

EULAR recommendations 2003: an evidence based

approach to the management of knee osteoarthritis:

report of a task force of the Standing Committee for

International Clinical Studies Including Therapeutic

Trials (ESCISIT).

Annals of the Rheumatic Disease

62

,

1145–1155.

National Institute for Clinical Excellence (2004) Guideline

development methods. Chapter 11: creating guideline

recommendations. Available at:

http://www.nice.org.uk/pdf/GDM_Chapter11.pdf

(accessed 13 July 2004).

New Zealand Guidelines Group (2004).

Grading Systems

for Guidelines.

Available at: http://www.nzgg.org.nz

(accessed 13 July 2004).

Pencharz J.N., Grigoriadis E., Jansz G.F. & Bombardier C.

(2002) A critical appraisal of clinical practice guidelines

for the treatment of lower-limb osteoarthritis.

Arthritis

Research

4

, 36–44.

Pendleton A., Arden N., Dougados M.

et al.

(2000)

EULAR recommendations for the management of knee

osteoarthritis: report of a task force of the Standing

Committee for International Clinical Studies Including

Therapeutic Trials (ESCISIT).

Annals of the Rheumatic

Disease

59

, 936–944.

Roddy E., Zhang W., Doherty M.

et al.

(2005) Evidencebased

recommendations for the role of exercise in the

management of osteoarthritis of the hip or knee – the

MOVE consensus.

Rheumatology

44

, 67–73.

Sackett D.L., Rosenberg W.M., Gray J.A., Haynes R.B. &

Richardson W.S. (1996) Evidence based medicine: what

it is and what it isn’t.

BMJ

312

, 71–72.

Shekelle P.G., Woolf S.H., Eccles M. & Grimshaw J. (1999)

Clinical guidelines: developing guidelines.

BMJ

318

,

593–596.

US Preventive Services Task Force Ratings (2003)

Strength

of Recommendations and Quality of Evidence. Guide to

Clinical Preventive Services

, 3rd edn. Periodic Updates,

2000–2003. Agency for Healthcare Research and Quality,

Rockville, MD. Available at:

http://www.ahrq.gov/clinic/3rduspstf/ratings.htm

(accessed 13 July 2004).

Zhang W., Doherty M., Arden N.

et al.

(2004) EULAR

evidence-based recommendations for the management

of hip osteoarthritis – report of a task force of the Standing

Committee for International Clinical Studies Including

Therapeutic Trials (ESCISIT).

Annals of the

Rheumatic Disease.

Published Online First: 7 October

2004, 10.1136/ard.2004.028886